Neuronetics (STIM) Tops Q3 EPS by 15c; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q3 EPS of ($0.28), $0.15 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $15.02 million.

GUIDANCE:

Neuronetics sees FY2022 revenue of $63-64 million, versus the consensus of $61.794 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• HP shares slide as tech giant forecasts 2027 PC market slump
• Ledyard Financial Group adds two directors, three retire
• Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh